Prognostic significance of scc antigen in the serum of patients with head and neck cancer

Tumor Biology

Volumn 17, Issue 2, 1996, Pages 81-89

  Molina, Rafael ^a   Torres, Maria D ^a   Moragas, Miguel ^a   Perez Villa, Jose ^a   Filella, Xavier ^a   Jo, Judith ^a   Farrus, Blanca ^a   Giménez, Nuria ^a   Traserra, José ^a   Ballesta, Antonio M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Head and neck tumors; Prognostic value; SCC antigen; Squamous cell carcinomas; Tumor markers; Tumor associated antigen

Indexed keywords

EID: 9044233640     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000217970     Document Type: Article

References (25)

1. Silverman NA, Alexander JC, Chretien PB: CEA levels in head and neck cancer. Cancer 1976:37:2204-2211.
2. Goet H, Kohli GS, Lai H: Serum phosphohexosc isomerase level in patients with head and neck cancer. J Laryngol Otol 1986;100:581-585.
3. Maxim PE, Veltri RWZ: Scrum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck. Cancer 1986:57: 305-311.
4. Kato H, Torigoe T: Radioimmunoassay for tumor-antigen of human cervical squamous cell carcinoma. Cancer 1977:40:1621-1628.
5. Kato H, Monoka H, Aramaki S Torigoe T: Radioimmunoassay for a tumor antigen of human cervical squamous cell carcinoma. Cell Mol Biol 1979:25:51-56.
6. Kato H, Morioka H, Tsutsui H, Aramaki S, Torigone T: Value of tumor antigen (Ta-4) of squamous cell carcinoma in predicting the extent of cervical cancer. Cancer 1982:50: 1294-1296.
7. Maruo T, Shibata K, Kimura A, Hoshina T, Mochizuki M: Turnor associated antigen Ta-4 in the monitoring of t he effects of therapy for squamous cell carcinoma of the uterine cervix. Cancer 1985:56:302-308.
8. Upham J, Campbell B: Utility of squamous cell carcinoma antigen (SCC Ag) as a tumour marker in pulmonary malignancy. Respir Med 1992;86:201-203.
9. Burtin P, Ben Bonali AK, Boyer J, Daver A, Larra F, Ronceray J: Diagnostic and prognostic value of serum levels of SCC antigen in patients with esophageal epidermoid carcinoma: Retrospective study of 64 patients: in Kato H, Ebert W, Herberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton, Excerpta Medica. 1987. pp 124-148.
10. Eibling CDF, Johnson JT, Wagner RL, Su S: SCC-Ria in the diagnosis of squamous cell carcinoma of the head and neck. Laryngoscope 1989: 99:117-124.
11. Shirato H, Ichimura W, Wakushima H, Nishioka T, Suzuki K: Squamous cell carcinoma antigen in scrum for monitoring of head and neck and uterine cervical squamous cell carcinoma after radiotherapy. Acta Oncol 1993:32:663-666.
12. Molina R, Agusti C, Mane JM. Filella X, Jo J, Joseph J, Gimenez N, Estape J, Ballesta AM: CYFRA 21-1 in lung cancer. Comparison with CEA, CA 125, SCC and NSE serum levels. Int J Biol Markers 1994:9: 96-101.
13. Molina R, Filella X, Torres MD, Ballesta AM, Mengual P, Cases A, Balague A: SCC antigen measured in malignant and nonmalignant diseases. Clin Chem 1990:36:251-254.
14. Mino N, Lio A, Uamamoto K: Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer 1988:62:730-734.
15. Molina R, Torres MD, Filella X, Mengual PJ, Arias C, Ballesta AM: Serum SCC antigen in patients with head and neck tumors. J Tumor Marker Oncol 1987;2:277-282.
16. Fischback W, Meyer Th, Barthel K: Squamous cell carcinoma antigen in the diagnosis and treatment follow-up of oral and facial squamous cell carcinoma. Cancer 1990:54:1321-1324.
17. Yamanaka N, Himi T, Harabuchi Y, Hoki K, Kataura A: Soluble immune complexes and squamous cell carcinoma-related antigens in patients with head and neck cancer. Cancer 1988:62:1932-1938.
18. Black DAK, Cameron JS: Renal function: in Brown SS, Mitchell FL, Young DS (eds): Chemical Diagnosis of Disease. Amsterdam, Elsevier North-Holland. 1979. pp 454-514.
19. Morioka H: Tumor antigen (TA-4) of squamous cell carcinoma. Its tissue distribution and its relationship to scrum TA-4 concentrations. Asia Oceania J Obstet Gynaecol 1980:6: 91-97.
20. Maruo T, Matsuo H, Nishino R: Discordant induction of tumor-associated antigen Ta-4 and chorionic gonadotropin B in cultured cervical carcinoma cells. Nippon Sanka Fu-jinka Gakkai Zasshi 1987:39:291-296.
21. Wobbes Th, Thomas CMG, Segers M FG: The squamous cell carcinoma tumor marker in mammary carcinoma: Comparison of polyclonal versus monoclonal antibody-based assays. Oncology 1990:47:14-18.
22. Kearsley JH, Slenzel DJ, Sculley TB, Cooke RA: Cellular localization of tumor antigen (TA-4) in normal, dvsplastic and neoplastic squamous epithelia of the upper aerodigestive tract. Br J Cancer 1990:61:631-635.
23. van der Sijde R, de Bruijn HWA, Krans M, Bounta J, Aalders JG: Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva. Gynecol Oncol 1989:35:227-232.
24. Torre GC, Chisale E, Barbini V, Rembado R, Bianchi D, Bugardini G, Capelli M, Plate L. Marabini A, Orlandi C, Cortesi E, Vecchione A: Determination of scrum levels of SCC antigen in patients with malignant and non-malignant gynecological disease: A multicentric study; in Kalo H, Ebert W, Heberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton. Excerpta Medica. 1987, pp 75-85.
25. Kato H, Morioka H, Aramaki S, Tamai K, Torigoe T: Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix. Am J Obstel Gynecol 1983;145:350-354.